Orbus Therapeutics Secures $32.5 Million Series A Financing to Advance Late-Stage Brain Cancer Drug
19 août 2015 11h00 HE
|
Orbus Therapeutics, Inc.
PALO ALTO, Calif., Aug. 19, 2015 (GLOBE NEWSWIRE) -- Orbus Therapeutics Inc., a private, clinical-stage biopharmaceutical company focused on the development and commercialization of therapies that...